CODX — Co-Diagnostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Co-Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	47.3	89.9	81.3	58.5	29.7
Net Total Accounts Receivable
Net Total Receivables	12.1	20.9	5.4	0.331	0.133
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	67.8	115	92.7	62.1	32.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.95	1.93	2.91	6	4.88
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	71.2	160	123	95.3	64
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.06	12.6	3.87	5.75	7.32
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	4.54	25.6	8.57	9.31	9.69
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	66.7	134	115	86	54.3
Total Liabilities & Shareholders' Equity	71.2	160	123	95.3	64
Total Common Shares Outstanding